DIVI S LABORATORIES LTD vs HESTER BIOSCIENCES LTD

A side-by-side comparison of DIVI S LABORATORIES LTD (DIVISLAB) and HESTER BIOSCIENCES LTD (HESTERBIO) — valuation, profitability, growth, and financial health — to help you judge which is the stronger buy today.

The verdict

On the numbers, DIVI S LABORATORIES LTD leads DIVISLAB vs HESTERBIO on 10 of 14 metrics. See the breakdown below — the right pick still depends on your goals (value vs growth, risk appetite).

  • Valuation13
  • Profitability40
  • Growth11
  • Size & financial health40
ValueReturnsMarginGrowthScaleLow debt

Each axis shows this group's split of that metric, scaled so the leader sits at the edge. Relative to each other, not an absolute score.

Valuation

HESTERBIO takes 3/4

How expensive each stock is relative to its earnings and book value. Lower usually means cheaper.

95.93
P/E ratio
33.21
10.62
P/B ratio
5.12
0.33%
Dividend yield
0.48%
₹96.73
EPS
₹65.41

Profitability

DIVISLAB takes 4/4

How efficiently each company turns capital and sales into profit. Higher is better.

16.50%
Return on equity
15.90%
22.00%
Return on capital
15.00%
33.00%
EBITDA margin
26.00%
24.32%
Net margin
17.12%

Growth

Even

Three-year compounded growth. Faster-growing businesses can justify a higher valuation.

10.78%
Revenue CAGR (3Y)
7.78%
12.10%
Profit CAGR (3Y)
26.74%

Size & financial health

DIVISLAB takes 4/4

Scale and balance-sheet strength. Bigger revenue/profit and lower debt are generally safer.

₹2.45L Cr
Market cap
₹1,852 Cr
₹10,560 Cr
Revenue
₹333 Cr
₹2,568 Cr
Net profit
₹57 Cr
0.00
Debt / equity
0.19
DIVI S LABORATORIES LTD
  • + ["Company is almost debt free.", "Company has been maintaining a healthy dividend payout of 39.0%"]
  • ["Stock is trading at 14.6 times its book value", "The company has delivered a poor sales growth of 8.67% over past five years."]
HESTER BIOSCIENCES LTD
  • + ["Company has been maintaining a healthy dividend payout of 21.8%", "Company's working capital requirements have reduced from 80.2 days to 54.4 days"]
  • ["Stock is trading at 5.44 times its book value", "The company has delivered a poor sales growth of 9.19% over past five years.", "Company has a low return on equity of 10.8% over last 3 years.", "Company might be capitalizing the interest cost", "Earnings include an other income of Rs.105 Cr."]
DIVI S LABORATORIES LTD full analysis HESTER BIOSCIENCES LTD full analysis

This comparison is for informational purposes only and is not investment advice. Please consult a SEBI-registered advisor before investing.

DIVISLAB vs HESTERBIO: Share Price, Valuation & Which to Buy | DocStoX